AG Mednet and Median Technologies Partnership Supports Global Clinical Trials Portfolio Including Extensive Programs...
Median Technologies, The Imaging Phenomics Company and AG Mednet have renewed their partnership to use AG Mednet’s global infrastructure for the collection, QC and...
Clinerion continues expansion of Patient Network Explorer coverage in South America by partnering with...
The Chilean company B-TRIALS, a specialist in providing tools and solutions in the health area, will be responsible for the expansion of Clinerion in...
QuickSTAT Opens Facility to Support Clinical Trials in Key US Biotech Hub Raleigh Durham...
QuickSTAT, part of the Kuehne + Nagel Group, has announced the opening of a new GDP (Good Distribution Practices) compliant package conditioning facility that...
Under the spotlight: Amgen’s VP for the Center of Observational Research Will Discuss the...
Amidst a (r)evolution in pharmaceutical strategy, Real World Evidence is more than ever a key driver of growing innovation in product life cycle.
Leading organizations...
Clinerion partners with 2 GL Outsourcing to bring patients and hospitals in Serbia and...
2 GL Outsourcing is a dynamic and highly flexible pharmaceutical and clinical contract research and outsourcing organization providing a full range of professional services...
Symposium tackles adulteration of botanical ingredients
Mollet del Valles (Spain), Following the great success of last year’s workshop, Euromed is once again partnering with the American Botanical Council (ABC), Extrasynthese,...
Advancing the use & generation of Real World Evidence across drug life cycle
Real World Evidence is at the root of an ongoing and critical transformation in medical care. By incorporating data from the real-world into their...
Antibodies com Raises 400000 Pre Seed Round to Help Researchers Discover More For Less
Antibodies.com, a digital marketplace that enables life scientists to purchase critical research reagents at cost-effective prices from the primary manufacturers, announced that is has...
EMA Validates Santheras Marketing Authorization Application for Puldysain Duchenne Muscular Dystrophy
"The initiation of the CHMP review of our application is an important milestone for patients with DMD who currently have no alternative treatment for...
Cobra Biologics, Symbiosis complete 4.8M viral vector supply chain collaboration
Cobra Biologics, an international contract development and manufacturing organisation (CDMO) focused on viral vector drug substance production, and Symbiosis Pharmaceutical Services (Symbiosis), a contract...
